Search results for "FAS"

showing 10 items of 2015 documents

‚ÄûExtracorporeal shock wave therapy for plantar fasciitis‚Äìa double blind randomised controlled trial‚Äù by C. A. Speed et al., J Orthop res 2003;2…

2004

medicine.medical_specialtyExtracorporeal shock wave therapybusiness.industryPlantar fasciitismedicine.diseaseSurgerylaw.inventionDouble blindRandomized controlled triallawPhysical therapyMedicineOrthopedics and Sports Medicinemedicine.symptombusinessFasciitisJournal of Orthopaedic Research
researchProduct

Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1997

The mechanisms responsible for thyrocyte destruction in Hashimoto's thyroiditis (HT) are poorly understood. Thyrocytes from HT glands, but not from nonautoimmune thyroids, expressed Fas. Interleukin-1β (IL-1β), abundantly produced in HT glands, induced Fas expression in normal thyrocytes, and cross-linking of Fas resulted in massive thyrocyte apoptosis. The ligand for Fas (FasL) was shown to be constitutively expressed both in normal and HT thyrocytes and was able to kill Fas-sensitive targets. Exposure to IL-1β induced thyrocyte apoptosis, which was prevented by antibodies that block Fas, suggesting that IL-1β-induced Fas expression serves as a limiting factor for thyrocyte destruction. Th…

medicine.medical_specialtyFas Ligand Proteinmedicine.medical_treatmentThyroid GlandApoptosisPolymerase Chain ReactionThyroiditisFas ligandPathogenesisImmunoenzyme TechniquesInternal medicinemedicineTumor Cells CulturedHumansRNA Messengerfas ReceptorCells CulturedNucleic Acid Synthesis InhibitorsProtein Synthesis InhibitorsMultidisciplinaryMembrane GlycoproteinsChemistryThyroidThyroiditis AutoimmuneInterleukinAntibodies Monoclonalmedicine.diseaseFas receptorRecombinant ProteinsCytokinemedicine.anatomical_structureEndocrinologyApoptosisCytokinesInterleukin-1
researchProduct

Is the El Niño-Southern Oscillation likely to increase the risk of Fasciola transmission?

2007

(2007). Is the El Nino–Southern Oscillation likely to increase the risk of Fasciola transmission? Annals of Tropical Medicine & Parasitology: Vol. 101, No. 6, pp. 555-557.

medicine.medical_specialtyFascioliasisMeteorological ConceptsSnailsDisease Vectorslaw.inventionDisease OutbreakslawRisk FactorsmedicineOscillation (cell signaling)AnimalsHumansRisk factorWeatherTropical ClimateFasciolabiologybiology.organism_classificationFasciolaInfectious DiseasesEl Niño Southern OscillationTransmission (mechanics)El NiñoClimatologyTropical medicineParasitologyCattleAnnals of tropical medicine and parasitology
researchProduct

Steroid-resistant eosinophilic fasciitis successfully treated with addition of extracorporeal photopheresis.

2019

Eosinophilic fasciitis (EF) is an uncommon fibrosing disease of the fascia with characteristic cutaneous and hematologic manifestations. Although EF is most commonly treated with corticosteroids at the beginning, a considerable number of patients show an inadequate response and hence various therapeutic strategies have been tried, including extracorporeal photopheresis (ECP). We describe the case of a 66-year-old woman with steroid-resistant EF that improved significantly after ECP was added to her treatment regimen. To date, only six cases of this therapeutic strategy have been reported in English literature.

medicine.medical_specialtyFibrosing diseaseDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineExtracorporeal PhotopheresisEosinophiliamedicineHumansFasciitisGlucocorticoidsTherapeutic strategyAgedTreatment regimenbusiness.industryGeneral MedicineFasciamedicine.diseaseDermatologySteroid resistantEosinophilic fasciitismedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisPhotopheresisFemalebusinessDermatologic therapy
researchProduct

Effectiveness of the PROMUFRA program in pre-frail, community-dwelling older people: A randomized controlled trial.

2020

Abstract This study evaluated the effect of PROMUFRA program on physical frailty, kinanthropometric, muscle function and functional performance variables in pre-frail, community-dwelling older people. Participants (n = 50, 75 ± 7 years) were randomly assigned to two groups: intervention group (IG), and control group (CG). The IG performed multi-component exercise program, focused on high-intensity resistance training (HIRT) combined with self-massage for myofascial release (SMMR) for 12 weeks (2 d.wk−1). Two measurements were performed, at baseline and post-3 months. Participants (n = 43) were analyzed and significant differences were found in group-time interaction for muscle mass (p = 0.0…

medicine.medical_specialtyFrail ElderlyIsometric exerciseIntervention grouplaw.invention03 medical and health sciences0302 clinical medicineExercise programRandomized controlled triallawmedicineHumans030212 general & internal medicineMuscle StrengthLeg pressExerciseAgedFrailtybusiness.industryResistance trainingResistance TrainingMyofascial releaseExercise TherapyPhysical therapyIndependent LivingOlder peoplebusinessGerontology030217 neurology & neurosurgeryGeriatric nursing (New York, N.Y.)
researchProduct

Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.

2004

Background & Aims: The HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a life-threatening complication during pregnancy. The associated liver disease may be severe, and maternal hepatic complications may progress to the point that transplantation becomes necessary. CD95 (APO-1, Fas)-mediated apoptosis of liver cells is one of the major pathogenic mechanisms during liver disease. The interaction of CD95 with its ligand, CD95L(FasL), induces apoptosis and thus the source of the death-inducing ligand is critical for understanding the pathomechanism of liver damage involving the CD95-system. Methods: Sera from HELLP patients were analyzed and used in cell culture experiment…

medicine.medical_specialtyHELLP SyndromeFas Ligand ProteinHELLP syndromePlacentaApoptosisBiologyHepatic ComplicationFas ligandAcute fatty liver of pregnancyLiver diseaseJurkat CellsMicePregnancyInternal medicinemedicineAnimalsHumansCells CulturedTransaminasesMembrane GlycoproteinsHepatologymedicine.diagnostic_testLiver cellGastroenterologymedicine.diseaseHemolysisMolecular WeightEndocrinologyLiverCancer researchHepatocytesFemaleLiver function testsGastroenterology
researchProduct

A Randomised-Controlled Clinical Study Examining the Effect of High-Intensity Laser Therapy (HILT) on the Management of Painful Calcaneal Spur with P…

2021

Calcaneal spur and plantar fasciitis are the most common causes of plantar heel pain. There are many effective physical modalities for treating this musculoskeletal disorder. So far, the are no clear recommendations confirming the clinical utility of high-intensity laser therapy (HILT) in the management of painful calcaneal spur with plantar fasciitis. This study aimed to evaluate the effectiveness of HILT in pain management in patients with calcaneal spur and plantar fasciitis. A group of 65 patients was assessed for eligibility based on the CONSORT guidelines. This study was prospectively registered in the Australian New Zealand Clinical Trial Registry platform (registration number ACTRN1…

medicine.medical_specialtyHeelLaitinen Pain ScaleVisual analogue scaleAnalgesicPlantar fasciitisArticleMusculoskeletal disorderhigh-intensity laser therapyVisual Analogue Scalemedicinebusiness.industryRcalcaneal spurGeneral MedicinePain scalemedicine.diseaseSurgeryClinical trialmedicine.anatomical_structurepain managementMedicinemedicine.symptomplantar fasciitisbusinessCalcaneal spurJournal of clinical medicine
researchProduct

Effectiveness of low-energy extracorporal shock waves for chronic plantar fasciitis

1996

Summary Over a period of 4 years we performed a prospective randomized trial on 100 patients in order to compare the effects of low-energy extracorporal shock-wave therapy (ESWT) in the treatment of painful heel (chronic plantar fasciitis). Patients in group I were treated three times at weekly intervals with 1000 impulses of 0.08 mJ/mm 2 given around the heel spur. Group II received treatment three times with 10 impulses of the same energy density at weekly intervals. Follow-up examinations were done at 12 and 52 weeks, respectively. The main outcomes assessed were reduction in severity of pressure pain, period of pain-free walking, and patient satisfaction. At 12 weeks, 16 of 50 patients …

medicine.medical_specialtyHeelbusiness.industryGroup iiPlantar fasciitisPain freeSurgerylaw.inventionmedicine.anatomical_structurePatient satisfactionLow energyRandomized controlled triallawmedicineEnergy densityOrthopedics and Sports Medicinemedicine.symptombusinessFoot and Ankle Surgery
researchProduct

Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

2017

medicine.medical_specialtyIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismBiochemistryOutcome (game theory)EndocrinologyInternal medicineGeneticsmedicineIn patientbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

Microscopic Endonasal Surgery for Repair of CSF Leaks

1993

This manuscript will detail our experience using a microscopic endonasal surgery (MES) approach in the repair of spontaneous, traumatic, and/or iatrogenic cerebrospinal fluid (CSF) fistula into the ethmoid and sphenoid sinuses. The location of the fistula in 22 patients was determined by a direct endoscopic or microscopic visualization, intrathecal fluorescein, or computed tomography (CT) with metrizamide. Several of these patients had been treated unsuccessfully with previous neurosurgical, intracranial, and extracranial approaches to stop the leak. The CSF fistulas in all these patients were repaired with a MES approach, packing the leak with either a septal mucosal graft, or abdominal f…

medicine.medical_specialtyLeakrhinorrheabusiness.industryFistulaFasciamedicine.diseaseSurgery03 medical and health scienceschemistry.chemical_compoundDissection0302 clinical medicinemedicine.anatomical_structureCerebrospinal fluidOtorhinolaryngologychemistry030220 oncology & carcinogenesisMetrizamidemedicineAbdominal fatmedicine.symptom030223 otorhinolaryngologybusinessAmerican Journal of Rhinology
researchProduct